Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novacel (Novacel Ophtalmique) is a leading French manufacturer of ophthalmic lenses and optical equipment, serving as a major player in the European eye care market. Founded in 1994 and headquartered in Château-Thierry, the company operates one of the most technologically advanced production facilities in the region, specializing in the design and surfacing of high-precision corrective lenses. Since its acquisition by Essilor (now EssilorLuxottica) in 2007, Novacel has maintained its operational independence and brand identity, focusing on "Origine France Garantie" certified products. The company's portfolio includes a wide range of progressive, single-vision, and specialty lenses, as well as contact lenses and diagnostic instruments for optical professionals. Novacel is recognized for its innovation in lens coatings, blue light protection, and its exclusive partnership to manufacture Leica-branded ophthalmic lenses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novacel.